Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: EdiG ...
"

And I would submit very un-lawyerlike to post

"USPTO Rejects '584 Patent"

when accuracy would dictate

"USPTO Rejects Claim 29 of the '584 Patent"

Unless of course he has an agenda. "

I'd actually go a step further..... It appears that the reality of the situation would dictate wording like:

"The USPTO calls into question Claim 29 of patent '548",

because that's all that has really happened. It's a non-final rejection, subject to further review based on input solely from the TPL/PTSC technical/legal team.

"Much ado about very little" at this point, IMHO.

And you make a good point re: timing and the '148 and '336. Did they pass muster? I would suspect so. And I'm sure "lurking" would avoid posting THAT bit of news.

Thanks for giving me a hand yesterday. It appears that the Agora posting limit is more like 20, and in any 24 hour period.

SGE

Share
New Message
Please login to post a reply